Study published in Clinical Genitourinary Cancer argues multidisciplinary efforts are key to accelerating implementation of integrated germline genetic services for personalized treatment and clinical trial eligibility.
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.